AAPS PharmSci 360 Opening and Closing Plenary Speakers Announced
Registration for Oct. 22-25 Conference Now Open
Arlington, VA—AAPS is excited to announce the opening and closing plenary speakers for the PharmSci 360 conference (October 22-25, in Orlando, FL).
Thomas Hartung, MD, PhD, will deliver the opening plenary on Sunday, Oct. 22, 2023. He is currently the Doerenkamp- Zbinden-Chair for Evidence-based Toxicology in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health and Whiting School of Engineering in Baltimore. He is Field Chief Editor of Frontiers in Artificial Intelligence and is the former Head of the European Commission’s Center for the Validation of Alternative Methods (ECVAM).
Julie A. DeMartino, PhD, an independent consultant, will deliver the closing plenary on Wednesday, Oct. 25. She has been involved in drug discovery R&D with more than 3 decades of basic research and translational medicine experience. Following leadership roles at Merck & Co., Roche, and Merck KGaA, DeMartino founded her consulting firm, AcheneRx LLC, in 2021, to help pharma and biotech firms develop novel drug treatments for debilitating and progressive disease.
“I’m excited about the opening and closing plenary talks at this year’s PharmSci 360,” AAPS Executive Director Tina Morris, PhD, said. “Both talks will bookend a conference rich in innovation and full of the latest developments in pharmaceutical science. It will allow ample opportunities for attendees to discuss these advancements with colleagues from across pharma.”
“We are very pleased to confirm the speakers for our opening and closing plenaries at PharmSci 360,” AAPS 2023 PharmSci 360 Scientific Programming Committee Chair Otilia Koo said. “Drs. Hartung and DeMartino will speak to the latest developments in pharmaceutical sciences and provide their invaluable insights that attendees can use to progress both their research and career development, which are the important objectives of the conference.”
Registration is now open for the 2023 PharmSci 360 conference: http://www.aaps.org/pharmsci/register.
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.orgFor more information: Rebecca Stauffer AAPS Communications Manager firstname.lastname@example.org